Evidence map›Paper›PMID 35654469›Full record

ArticleBMJ open2022

Intention to vaccinate against COVID-19 and adherence to non-pharmaceutical interventions against COVID-19 prior to the second wave of the pandemic in Uganda: a cross-sectional study.

Solomon Tsebeni Wafula, Innocent B Mugume, Benjamin Sensasi, Solome Okware, Alexander Chimbaru, Miriam Nanyunja, Ambrose Talisuna, Richard Kabanda, Tabley Bakyaita, Rhoda K Wanyenze and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Solomon Tsebeni WafulaDepartment of Disease Control and Environmental Health, Makerere University College of Health Sciences, Kampala, Uganda swafula@musph.ac.ug.ORCID 0000-0002-6405-015X
Innocent B MugumeDepartment of Disease Control and Environmental Health, Makerere University College of Health Sciences, Kampala, Uganda.
Benjamin SensasiWHO Country Office for Uganda, Kampala, Uganda.
Solome OkwareWHO Country Office for Uganda, Kampala, Uganda.
Alexander ChimbaruWHO Sierra Leone Country Office, Freetown, Sierra Leone.
Miriam NanyunjaRegional Office for Africa, Eastern and Southern Africa Hub, World Health Organization, Nairobi, Kenya.
Ambrose TalisunaWorld Health Organization, WHO, Brazzaville, Congo.ORCID 0000-0001-6436-3415
Richard KabandaMinistry of Health, Republic of Uganda, Kampala, Uganda.
Tabley BakyaitaMinistry of Health, Republic of Uganda, Kampala, Uganda.
Rhoda K WanyenzeDepartment of Disease Control and Environmental Health, Makerere University College of Health Sciences, Kampala, Uganda.
Jayne Byakika-TusiimeRegional Office for Africa, Eastern and Southern Africa Hub, World Health Organization, Nairobi, Kenya.
Makerere University · UGWorld Health Organization - Pakistan · PKMinistry of Health · UGWorld Health Organization - Uganda · UGUniversity of Sierra Leone · SL

Funding

World Health Organization 001
6 · The paper itself

Abstract

objectivesThe resurgence in cases and deaths due to COVID-19 in many countries suggests complacency in adhering to COVID-19 preventive guidelines. Vaccination, therefore, remains a key intervention in mitigating the impact of the COVID-19 pandemic. This study investigated the level of adherence to COVID-19 preventive measures and intention to receive the COVID-19 vaccine among Ugandans. DESIGN, SETTING AND

participantsA nationwide cross-sectional survey of 1053 Ugandan adults was conducted in March 2021 using telephone interviews.

main outcome measuresParticipants reported on adherence to COVID-19 preventive measures and intention to be vaccinated with COVID-19 vaccines.

resultsOverall, 10.2% of the respondents adhered to the COVID-19 preventive guidelines and 57.8% stated definite intention to receive a SARS-CoV-2 vaccine. Compared with women, men were less likely to adhere to COVID-19 guidelines (Odds Ratio (OR)=0.64, 95% CI 0.41 to 0.99). Participants from the northern (4.0%, OR=0.28, 95% CI 0.12 to 0.92), western (5.1%, OR=0.30, 95% CI 0.14 to 0.65) and eastern regions (6.5%, OR=0.47, 95% CI 0.24 to 0.92), respectively, had lower odds of adhering to the COVID-19 guidelines than those from the central region (14.7%). A higher monthly income of ≥US$137 (OR=2.31, 95% CI 1.14 to 4.58) and a history of chronic disease (OR=1.81, 95% CI 1.14 to 2.86) were predictors of adherence. Concerns about the chances of getting COVID-19 in the future (Prevalence Ratio (PR)=1.26, 95% CI 1.06 to 1.48) and fear of severe COVID-19 infection (PR=1.20, 95% CI 1.04 to 1.38) were the strongest predictors for a definite intention, while concerns for side effects were negatively associated with vaccination intent (PR=0.75, 95% CI 0.68 to 0.83).

conclusionBehaviour change programmes need to be strengthened to promote adherence to COVID-19 preventive guidelines as vaccination is rolled out as another preventive measure. Dissemination of accurate, safe and efficacious information about the vaccines is necessary to enhance vaccine uptake.

Indexed as

COVID-19VaccinesAdultCOVID-19 VaccinesCross-Sectional StudiesFemaleHumansIntentionMalePandemicsSARS-CoV-2UgandaVaccinationCOVID-19 VaccinesVaccinesCOVID-19epidemiologypublic health

Identifiers

PMID35654469
PMCPMC9163003
OpenAlexW4281885525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.